Apoptosis and its regulation

Advances in Experimental Medicine and Biology

Volumn 406, Issue , 1996, Pages 11-20

  Cohen, J John ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN P53;

APOPTOSIS; CELL DEATH; GENETIC REGULATION; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW;

EID: 0029859383     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-0274-0_2     Document Type: Review

References (88)

1. J.F.R. Kerr, A.H. Wyllie, and A.R. Currie. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br. J. Cancer 26:239 (1972).
2. H.M. Ellis and H.R. Horvitz. Genetic control of programmed cell death in the nematode C. elegans, Cell 44:817 (1986).
3. R.A. Lockshin and J. Beaulaton. Programmed cell death. Life Scid. 15:1549 (1974).
4. G.J. Deenen, I. van Balen, and D. Opstelten. In rat B lymphocyte genesis sixty percent is lost from the bone marrow at the transition of nondividing pre-B cell to sIgM+ B lymphocyte, the stage of Ig light chain gene expression. Eur. J. Immunol. 20:557 (1990).
5. J.S. Savill, A.H. Wyllie, J.E. Henson, M.J. Walport, P.M. Henson, and C. Haslett. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages, J. Clin. Invest. 83:865 (1989).
6. E.J. Jenkinson, R. Kingston, C.A. Smith, G.T. Williams, and J.J.T. Owen. Antigen-induced apoptosis in developing T cells: a mechanism for negative selection of the T cell receptor repertoire, Eur. J. Immunol. 19:2175 (1989).
7. R.C. Duke and J.J. Cohen. IL-2 addiction: withdrawl of growth factor activates a suicide program in dependent T cells, Lymphokine Res. 5:289 (1986).
8. A. Glucksmann. Cell deaths in normal vertebrate ontogeny, Biol. Revs. 26:59 (1951).
9. R.C. Duke, R. Chervenak, and J.J. Cohen. Endogenous endonuclease-induced DNA fragmentation: An early event in cell-mediated cytolysis, Proc. Natl. Acad. Sci. U. S. A. 80:6361 (1983).
10. E. Durkheim, "Suicide, A Study in Sociology", Free Press, Glencoe (1951).
11. J. Yuan and H.R. Horvitz. The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death, Dev. Biol. 138:33 (1990).
12. A.H. Wyllie. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous nuclease activation, Nature 284:555 (1980).
13. C.A. Smith, G.T. Williams, R. Kingston, E.J. Jenkinson, and J.J.T. Owen. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures, Nature 337:181 (1989).
14. lo thymocytes in vivo, Science 250:1720 (1990).
15. K.S. Sellins and J.J. Cohen. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes, J. Immunol. 139:3199 (1987).
16. D.J. McConkey, P. Hartzell, S.K. Duddy, H. Hakansson, and S. Orrenius. 2,3,7,8-Tetrachlorodibenzo-p-dioxin kills immature thymocytes by Ca++-mediated endonuclease activation. Science 242:256 (1988).
17. K.S. Sellins and J.J. Cohen. Hyperthermia induces apoptosis in thymocytes. Radiat. Res. 126:88 (1991).
18. C.J. Sanderson, Morphological aspects of lymphocyte mediated cytotoxicity, in: "Mechanisms of Cell-Mediated Cytotoxicity", W.R. Clark, and P. Golstein, eds. Plenum Press, New York (1982).
19. G.C. Godman, A.F. Miranda, A.D. Deitch, and S.W. Tanenbaum. Action of cytochalasin D on cells of established lines. III Zeiosis and movements at the cell surface, J. Cell Biol. 64:644 (1975).
20. L. Fesus, P.J. Davies, and M. Piacentini. Apoptosis: molecular mechanisms in programmed cell death, Eur. J. Cell Biol. 56:170 (1991).
21. M.A. Kolber, K.O. Broschat, and B. Landa-Gonzalez. Cytochalasin B induces cellular DNA fragmentation, FASEB J. 4:3021 (1990).
22. N.P. Matylevich, B.A. Korol, P.A. Nelipovich, V.N. Afanasev, and S.R. Umansky. [D2O inhibition of interphase thymocyte death], Radiobiologiia 31:27 (1991).
23. Blumenthal, D.K. and Krebs, E.G. Calmodulin-binding domains. In: Calmodulin, edited by Cohen, P. and Klee, C.B. Amsterdam: Elsevier, 1988, p. 341-355.
24. S.J. Martin, G.A. O'Brien, W.K. Nishioka, A.J. McGahon, A. Mahboubi, T.C. Saido, and D.R. Green. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis, J. Biol. Chem. 270:6425 (1995).
25. V.A. Fadok, D.R. Voelker, P.A. Campbell, J.J. Cohen, D.L. Bratton, and P.M. Henson. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages, J. Immunol. 148:2207 (1992).
26. V.A. Fadok, J.S. Savill, C. Haslett, D.L. Bratton, D.E. Doherty, P.A. Campbell, and P.M. Henson. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells, J. Immunol. 149:4029 (1992).
27. J.S. Savill, V. Fadok, P. Henson, and C. Haslett. Phagocyte recognition of cells undergoing apoptosis, Immunol. Today 14:131 (1993).
28. L.C. Meagher, J.S. Savill, A. Baker, R.W. Fuller, and C. Haslett. Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2, J. Leukoc. Biol. 52:269 (1992).
29. A.H. Wyllie, Cell death: a new classification separating apoptosis from necrosis, in: "Cell Death in Biology and Pathology", I.D. Bowen and R.A. Lockshin, eds., Chapman & Hall, London (1981).
30. J.A. Cidlowski. Glucocorticoids stimulate ribonucleic acid degradation in isolated rat thymic lymphocytes in vitro, Endocrinology 111:184 (1982).
31. R.G. MacDonald and J.A. Cidlowski. Glucocorticoid-stimulated protein degradation in lymphocytes: quantitation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, Arch. Biochem. Biophys. 212:399 (1981).
32. T. Crompton, M.C. Peitsch, H.R. MacDonald, and J. Tschopp. Propidium iodide staining correlates with the extent of DNA degradation in isolated nuclei, Biochem. Biophys. Res. Commun. 183:532 (1992).
33. C. Dive, C.D. Gregory, D.J. Phipps, D.L. Evans, A.E. Milner, and A.H. Wyllie. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry, Biochim. Biophys. Acta 1133:275 (1992).
34. M.G. Ormerod, M.K. Collins, G. Rodriguez-Tarduchy, and D. Robertson. Apoptosis in interleukin-3-dependent haemopoietic cells. Quantification by two flow cytometric methods, J. Immunol. Methods 153:57 (1992).
35. X.-M. Sun, R.T. Snowden, D.N. Skilleter, D. Dinsdale, M.G. Ormerod, and G.M. Cohen. A flow-cytometric method for the separation and quantitation of normal and apoptotic thymocytes, Anal. Biochem. 204:351 (1992).
36. W.G. Telford, L.E. King, and P.J. Fraker. Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry, Cytometry 13:137 (1992).
37. Z. Darzynkiewicz, S. Bruno, G. Del Bino, W. Gorczyca, M.A. Hotz, P. Lassota, and F. Traganos. Features of apoptotic cells measured by flow cytometry, Cytometry 13:795 (1992).
38. G.M. Cohen, X.-M. Sun, R.T. Snowden, D. Dinsdale, and D.N. Skilleter. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation, Biochem. J. 286:331 (1992).
39. K.S. Sellins and J.J. Cohen. Cytotoxic T lymphocytes induce different types of DNA damage in target cells of different origins, J. Immunol. 147:795 (1991).
40. G.M. Cohen, X.M. Sun, H. Fearnhead, M. MacFarlane, D.G. Brown, R.T. Snowden, and D. Dinsdale. Formation of large molecular weight fragments of DNA is a key committed step of apoptosis in thymocytes, J. Immunol. 153:507 (1994).
41. D.J. McConkey, P. Hartzell, P. Nicotera, and S. Orrenius. Calcium-activated DNA fragmentation kills immature thymocytes, FASEB J. 3:1843 (1989).
42. Y.F. Shi, M.G. Szalay, L. Paskar, M. Boyer, B. Singh, and D.R. Green. Activation-induced cell death in T cell hybridomas is due to apoptosis. Morphologic aspects and DNA fragmentation, J. Immunol. 144:3326 (1990).
43. T. Crompton. IL3-dependent cells die by apoptosis on removal of their growth factor. Growth Factors 4:109 (1991).
44. M.D. Jacobson, J.F. Burne, and M.C. Raff. Programmed cell death and Bcl-2 protection in the absence of a nucleus, EMBO J. 13:1899 (1994).
45. J.J. Cohen. Programmed cell death in the immune system. Adv. Immunol. 50:55 (1991).
46. S.V. Lennon, S.J. Martin, and T.G. Cotter. Induction of apoptosis (programmed cell death) in tumour cell lines by widely diverging stimuli, Biochem. Soc. Trans. 18:343 (1990).
47. J.J. Cohen and R.C. Duke. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death, J. Immunol. 132:38 (1984).
48. G.I. Evan, A.H. Wyllie, C.S. Gilbert, T.D. Littlewood, H. Land, M. Brooks. C.M. Waters, L.Z. Penn, and D.C. Hancock. Induction of apoptosis in fibroblasts by c-myc protein, Cell 69:119 (1992).
49. Y.F. Shi, J.M. Glynn, L.J. Guilbert, T.G. Cotter, R.P. Bissonnette, and D.R. Green. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257:212 (1992).
50. L. Rao, M. Debbas, P. Sabbatini, D.M. Hockenbery, S.J. Korsmeyer, and E. White. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins, Proc. Natl. Acad. Sci. U. S. A. 89:7742 (1992).
51. J. Yuan and H.R. Horvitz. The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death, Development 116:309 (1992).
52. J. Yuan, S. Shaham, S. Ledoux, H.M. Ellis, and H.R. Horvitz. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75:641 (1993).
53. P. Li, H. Allen, S. Banerjee, S. Franklin, L. Herzog, C. Johnston, J. McDowell, M. Paskind, L. Rodman, and J. Salfeld. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock, Cell 80:401 (1995).
54. M.K. Squier, A.C. Miller, A.M. Malkinson, and J.J. Cohen. Calpain activation in apoptosis, J. Cell Physiol. 159:229 (1994).
55. D. Ginsberg, D. Michael-Michalovitz, and M. Oren. Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein, Mol. Cell. Biol. 11:582 (1991).
56. E. Yonish-Rouach, D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6, Nature 352:345 (1991).
57. P. Shaw, R. Bovey, S. Tardy, R. Sahli, B. Sordat, and J. Costa. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line, Proc. Natl. Acad. Sci. U. S. A. 89:4495 (1992).
58. D.P. Lane. p53, guardian of the genome. Nature 358:15 (1992).
59. T.G. Graeber, C. Osmanian, T. Jacks, D.E. Housman, C.J. Koch, S.W. Lowe, and A.J. Giaccia. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379:88 (1996).
60. N. Itoh, S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis, Cell 66:233 (1991).
61. A. Oehm, I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B.C. Trauth, and et al.. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen, J. Biol. Chem. 267:10709 (1992).
62. R. Watanabe-Fukunaga, C.I. Brannan, N.G. Copeland, N.A. Jenkins, and S. Nagata. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis, Nature 356:314 (1992).
63. K.M. Debatin, C.K. Goldmann, R. Bamford, T.A. Waldmann, and P.H. Krammer. Monoclonal-antibody-mediated apoptosis in adult T-cell leukaemia, Lancet 335:497 (1990).
64. E. Rouvier, M.F. Luciani, and P. Golstein. Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity, J. Exp. Med. 177:195 (1993).
65. T. Suda and S. Nagata. Purification and characterization of the Fas-ligand that induces apoptosis, J. Exp. Med. 179:873 (1994).
66. F. Vignaux and P. Golstein. Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur. J. Immunol. 24:923 (1994).
67. G.H. Fisher, F.J. Rosenberg, S.E. Straus, J.K. Dale, L.A. Middleton, A.Y. Lin, W. Strober, M.J. Lenardo, and J.M. Puck. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome, Cell 81:935 (1995).
68. K.B. Elkon. Apoptosis in SLE - too little or too much? Clin. Exp. Rheumatol. 12:553 (1994).
69. J.D. Mountz, J. Wu, J. Cheng, and T. Zhou. Autoimmune disease. A problem of defective apoptosis, Arthritis Rheum. 37:1415 (1994).
70. D. Bellgrau, D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R.C. Duke. A role for CD95 ligand in preventing graft rejection, Nature 377:630 (1995).
71. D.L. Vaux, S. Cory, and J.M. Adams. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells, Nature 335:440 (1988).
72. T.J. McDonnell, G. Nunez, F.M. Platt, D.M. Hockenbery, L. London, J.P. McKearn, and S.J. Korsmeyer. Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population, Mol. Cell Biol. 10:1901 (1990).
73. D.L. Vaux, H.L. Aguila, and I.L. Weissman. Bcl-2 prevents death of factor-deprived cells but fails to prevent apoptosis in targets of cell mediated killing, Int. Immunol. 4:821 (1992).
74. L.T. Zhong, T. Sarafian, D.J. Kane, A.C. Charles, S.P. Mah, R.H. Edwards, and D.E. Bredesen. bcl-2 inhibits death of central neural cells induced by multiple agents, Proc. Natl. Acad. Sci. U. S. A. 90:4533 (1993).
75. J.C. Reed. Bcl-2 and the regulation of programmed cell death, J. Cell Biol. 124:1 (1994).
76. L.H. Boise, M. Gonzalez-Garcia, C.E. Postema, L. Ding, T. Lindsten, L.A. Turka, X. Mao, G. Nunez, and C.B. Thompson. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death, Cell 74:597 (1993).
77. S.J. Korsmeyer, J.R. Shutter, D.J. Veis, D.E. Merry, and Z.N. Oltvai. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death, Semin. Cancer Biol. 4:327 (1993).
78. R. Buttyan, C.A. Olsson, J. Pintar, C. Chang, M.G. Bandyk, P.Y. Ng, and I.S. Sawczuk. Induction of the TRPM-2 gene in cells undergoing programmed death, Mol. Cell. Biol. 9:3473 (1989).
79. G.A. Garden, M. Bothwell, and E.W. Rubel. Lack of correspondence between mRNA expression for a putative cell death molecule (SGP-2) and neuronal cell death in the central nervous system, J. Neurobiol. 22:590 (1991).
80. G.P. Owens, W.E. Hahn, and J.J. Cohen. Identification of mRNAs associated with programmed cell death in immature thymocytes, Mol. Cell. Biol. 11:4177 (1991).
81. T.J. Mahalik, W.E. Hahn, G.H. Clayton, and G.P. Owens. Programmed cell death in developing grafts of fetal substantia nigra, Exp. Neurol. 129:27 (1994).
82. S. Valera, N. Hussy, R.J. Evans, N. Adami, R.A. North, A. Suprenant, and G. Buell. A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP, Nature 371:516 (1994).
83. G.P. Owens and J.J. Cohen. Identification of genes involved in programmed cell death, Cancer Metastasis Revs. 11:149 (1992).
84. L. Meyaard, S.A. Otto, R.R. Jonker, M.J. Mijnster, R.P.M. Keet, and F. Miedema. Programmed death of T cells in HIV-1 infection. Science 257:217 (1992).
85. J.C. Ameisen and A. Capron. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis, Immunol. Today 12:102 (1991).
86. A.G. Laurent-Crawford, B. Krust, S. Muller, Y. Riviere, M.A. Rey-Cuille, J.M. Bechet, L. Montagnier, and A.G. Hovanessian. The cytopathic effect of HIV is associated with apoptosis, Virology 185:829 (1991).
87. N.K. Banda, J. Bernier, O.K. Kurahara, R. Kurde, N. Haigwood, R.P. Sekaly, and T.H. Finkel. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis, J. Exp. Med. 176:1099 (1992).
88. J.J. Cohen and M. al-Rubeai. Apoptosis-targeted therapies: the 'next big thing' in biotechnology? Trends. Biotechnol. 13:281 (1995).